PATENT CLAIM ANALYSIS

Application Number: 15893104
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["435", "475000"]

Abstract:
The present disclosure provides methods and kits for generating recombinant bacteriophage genomes. Specifically, the present technology provides methods of integrating a heterologous nucleic acid sequence into a bacteriophage DNA genome, and isolating recombinant bacteriophages that express the heterologous nucleic acid sequence.

Claim (Index 17):
The method of  claim 1 , wherein the open reading frame of the heterologous nucleic acid is operably linked to an expression control sequence that is capable of directing expression of the bioluminescent protein, the fluorescent protein, the chemiluminescent protein, or any combination thereof.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 88.0
- Lexical Diversity: 1.45161
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15893094', '15179912', '14293498', '15420936', '14523799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6006016465664482
- 35 USC 102 Novelty (BERT): 0.6250513145768554
- Combined Prediction Score: 0.603046613367489
- Mean Citation Score: 468.44034800000014
- Max Citation Score: 692.9609
- Similarity Product: 507.3683113732934

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test